Systemic chemotherapy plus cetuximab after complete surgery in the treatment of isolated colorectal peritoneal carcinoma: COCHISE phase II clinical trial

OBJECTIVE: The primary objective of this non-randomised phase II study was to evaluate the combination of systemic chemotherapy plus cetuximab after complete cytoreductive surgery (CCS) for treatment of isolated colorectal peritoneal carcinoma (CRPC). This multicentre, prospective phase II clinical...

Descripción completa

Detalles Bibliográficos
Autores principales: Evrard, Serge, Desolneux, Grégoire, Bellera, Carine, Esnaud, Thomas, Bécouarn, Yves, Collet, Denis, Chafai, Najim, Marchal, Francois, Cany, Laurent, Lermite, Emilie, Rivoire, Michel, Mathoulin-Pélissier, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647143/
https://www.ncbi.nlm.nih.gov/pubmed/31331370
http://dx.doi.org/10.1186/s13104-019-4476-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647143/
https://www.ncbi.nlm.nih.gov/pubmed/31331370
http://dx.doi.org/10.1186/s13104-019-4476-9

Ejemplares similares